Apexigen to Present at Investor Conferences in March and April 2021

On March 1, 2021 Apexigen, Inc., a clinical-stage biopharmaceutical company, reported that Xiaodong Yang, M.D., Ph.D., President and Chief Executive Officer, will present at the following upcoming investor conferences (Press release, Apexigen, MAR 1, 2021, View Source [SID1234575881]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Barclays Global Healthcare Conference being held March 9 to 11, 2021
The Company’s presentation will be available to conference registrants on Tuesday, March 9 at 2:25pm Eastern Time.

H.C. Wainwright Global Life Sciences Conference being held March 9 and 10, 2021
The Company’s presentation will be available on-demand to conference registrants.

In addition, Apexigen will be meeting with investors at the following investor conferences:

Cowen’s 41st Annual Healthcare Conference, being held March 1 to 4, 2021

Needham Virtual Healthcare Conference, being held April 12 to 15, 2021